Navigating medicine pricing in Turkiye: the pharmaceutical Euro exchange rate
In recent years, Turkiye’s pharmaceutical industry has grappled with significant economic challenges, not least of which is the frequent upward…
Pricing and Market Access
South Korean pricing reform suggests more flexible drug reimbursement negotiations
Keytruda and Opdivo: a decade review
US negotiations for first round of drugs reveal $6bn in Medicare savings
Colombia’s president signs law to strengthen pharmaceutical sector
Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy
The US Biosecure Act threatens to destabilise the pharmaceutical industry
UK’s antibiotic subscription funding model – a route to market sustainability?
